Publications by authors named "Rossano Cesari"

22Publications

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.

Clin Cancer Res 2018 04 16;24(8):1816-1823. Epub 2018 Mar 16.

University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-1922DOI Listing
April 2018

Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.

Ann Surg Oncol 2018 Mar 8;25(3):768-775. Epub 2017 Sep 8.

Division of Medical Oncology, University of Colorado Denver School of Medicine - Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-6082-1DOI Listing
March 2018

A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors.

Clin Cancer Res 2015 03 11;21(5):1044-51. Epub 2014 Nov 11.

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1116DOI Listing
March 2015

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.

Breast 2013 Oct 17;22(5):650-6. Epub 2013 Aug 17.

Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.037DOI Listing
October 2013

HMGA1 protein is a novel target of the ATM kinase.

Eur J Cancer 2008 Nov 8;44(17):2668-79. Epub 2008 Sep 8.

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli Federico II, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.07.033DOI Listing
November 2008

In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.

Proc Natl Acad Sci U S A 2008 Jul 23;105(30):10547-52. Epub 2008 Jul 23.

San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), San Raffaele Scientific Institute, 20132 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0711666105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2492493PMC
July 2008

Inactivation of the FHIT gene favors bladder cancer development.

Clin Cancer Res 2004 Nov;10(22):7607-12

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-0341DOI Listing
November 2004

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.

Cancer Gene Ther 2004 Sep;11(9):633-41

Dipartimento di Biologia e Patologia Cellulare e Molecolare, c/o Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Università di Napoli Federico II, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.cgt.7700745DOI Listing
September 2004

The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Proc Natl Acad Sci U S A 2003 Sep 22;100(20):11517-22. Epub 2003 Sep 22.

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1934602100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC208790PMC
September 2003

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.

Cancer Res 2003 Mar;63(6):1183-7

Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
March 2003

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Proc Natl Acad Sci U S A 2002 May;99(10):6955-60

Kimmel Cancer Center, Jefferson Medical College, 233 South 10th Street, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.102181599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC124510PMC
May 2002

Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane.

Carcinogenesis 2002 Apr;23(4):581-6

Dipartimento di Farmacologia, Università di Bologna, via Irnerio 48, 40126 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/23.4.581DOI Listing
April 2002